Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5226
WisdomTree Trust WisdomTree Emerging Markets Quality Dividend Growth Fund
DGRE
$141M
| $697K | ﹤0.01% |
22,246
-1,602
| -7% | -$48.2K |
|
|
SNCR
5227
DELISTED
Synchronoss Technologies
SNCR
| $696K | ﹤0.01% |
81,261
+62,464
| +332% | +$385K |
|
5228
Vanguard Ultra-Short Bond ETF
VUSB
$8.93B
| $693K | ﹤0.01% |
13,897
+537
| +4% | +$26.8K |
|
5229
NET Power
NPWR
$128M
| $692K | ﹤0.01% |
303,697
-632,671
| -68% | -$1.98M |
|
5230
iShares MSCI Norway ETF
ENOR
$92.6M
| $692K | ﹤0.01% |
24,029
-2,486
| -9% | -$69.7K |
|
|
FRMM
5231
Forum Markets
FRMM
$73.2M
| $691K | ﹤0.01% |
141,112
+139,759
| +10,330% | +$1.97M |
|
|
UFOX
5232
Defiance Space and Connective Tech ETF
UFOX
$840M
| $690K | ﹤0.01% |
10,801
+287
| +3% | +$18.5K |
|
|
EXEEL
5233
DELISTED
Expand Energy Corp Class C Warrants
EXEEL
| $687K | ﹤0.01% |
6,894
+5,408
| +364% | +$553K |
|
5234
iShares MSCI Brazil Small-Cap ETF
EWZS
$231M
| $687K | ﹤0.01% |
53,119
-194,207
| -79% | -$2.62M |
|
|
SWKH
5235
DELISTED
SWK Holdings
SWKH
| $682K | ﹤0.01% |
39,662
+9,005
| +29% | +$149K |
|
5236
ProShares Ultra Gold
UGL
$661M
| $680K | ﹤0.01% |
12,253
+3,232
| +36% | +$169K |
|
5237
Medallion Financial
MFIN
$226M
| $674K | ﹤0.01% |
65,456
+6,199
| +10% | +$62.1K |
|
5238
Dynagas LNG Partners
DLNG
$135M
| $673K | ﹤0.01% |
178,428
-158,023
| -47% | -$577K |
|
|
GPRF
5239
Goldman Sachs Access U.S. Preferred Stock and Hybrid Securities ETF
GPRF
$134M
| $673K | ﹤0.01% |
13,285
+6,282
| +90% | +$320K |
|
5240
Citizens & Northern Corp
CZNC
$441M
| $672K | ﹤0.01% |
33,333
-818
| -2% | -$16.3K |
|
5241
Pliant Therapeutics
PLRX
$66.9M
| $670K | ﹤0.01% |
548,962
-2,958,326
| -84% | -$4.44M |
|
|
EVF
5242
Eaton Vance Senior Income Trust
EVF
$90.1M
| $668K | ﹤0.01% |
126,683
+6,334
| +5% | +$34.1K |
|
5243
VanEck Energy Income ETF
EINC
$77.6M
| $666K | ﹤0.01% |
6,921
| – | – |
|
5244
Cardiff Oncology
CRDF
$65M
| $663K | ﹤0.01% |
235,834
-74,825
| -24% | -$174K |
|
5245
Immix Biopharma
IMMX
$619M
| $662K | ﹤0.01% |
126,622
+5,952
| +5% | +$24.5K |
|
|
MTLS
5246
Materialise
MTLS
$373M
| $660K | ﹤0.01% |
118,885
-14,815
| -11% | -$87.7K |
|
5247
Sanara MedTech
SMTI
$237M
| $659K | ﹤0.01% |
28,227
+10,210
| +57% | +$264K |
|
5248
Norwood Financial Corp
NWFL
$367M
| $659K | ﹤0.01% |
23,480
+9,403
| +67% | +$256K |
|
5249
Foghorn Therapeutics
FHTX
$305M
| $657K | ﹤0.01% |
121,727
+58,051
| +91% | +$263K |
|
5250
Tonix Pharmaceuticals
TNXP
$165M
| $657K | ﹤0.01% |
42,038
+26,363
| +168% | +$486K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.